Palko-Łabuz, A.; Maksymowicz, J.; Sobieszczańska, B.; Wikiera, A.; Skonieczna, M.; Wesołowska, O.; Środa-Pomianek, K.
Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity. Cancers 2021, 13, 2952.
https://doi.org/10.3390/cancers13122952
AMA Style
Palko-Łabuz A, Maksymowicz J, Sobieszczańska B, Wikiera A, Skonieczna M, Wesołowska O, Środa-Pomianek K.
Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity. Cancers. 2021; 13(12):2952.
https://doi.org/10.3390/cancers13122952
Chicago/Turabian Style
Palko-Łabuz, Anna, Jerzy Maksymowicz, Beata Sobieszczańska, Agnieszka Wikiera, Magdalena Skonieczna, Olga Wesołowska, and Kamila Środa-Pomianek.
2021. "Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity" Cancers 13, no. 12: 2952.
https://doi.org/10.3390/cancers13122952
APA Style
Palko-Łabuz, A., Maksymowicz, J., Sobieszczańska, B., Wikiera, A., Skonieczna, M., Wesołowska, O., & Środa-Pomianek, K.
(2021). Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity. Cancers, 13(12), 2952.
https://doi.org/10.3390/cancers13122952